The Ki-67 proliferation marker is a useful prognostic tool in acromegalic patients

  • Published 2008 in
    Nature Clinical Practice Endocrinology…

Abstract

efficacy, but the available studies are plagued by methodological problems that call their findings into question. Murray and Melmed reviewed studies that compared octreotide LAR, lanreotide SR and lanreotide Autogel®. The small advantage of octreotide LAR over lanreotide SR in terms of symptom and biochemical control might have resulted from all patients… (More)
DOI: 10.1038/ncpendmet0905

Topics

Cite this paper

@article{2008TheKP, title={The Ki-67 proliferation marker is a useful prognostic tool in acromegalic patients}, author={}, journal={Nature Clinical Practice Endocrinology &Metabolism}, year={2008}, volume={4}, pages={475-475} }